Sylentis Announces the Clinical Results of Tivanisiran for the Treatment of Dry Eye Syndrome Read more
Ferring Signs Global Agreement to Commercialise Novel Gene Therapy for Bladder Cancer Patients Read more
Novartis receives FDA approval of Tafinlar + Mekinist for adjuvant treatment of BRAF V600-mutant melanoma Read more
Merck KGaA, Darmstadt, Germany to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group Read more